ClinicalTrials.gg
RecruitingNCT06272422HIP3DUpdated May 19, 2026

Comparison of the Restoration of Hip Biomechanical Parameters by CT Measurement Between the 3 Surgical Techniques: RSA/Minihip/THA - Hip Replacement: 3D Planning

An observational study in Coxarthrosis, sponsored by University Hospital, Lille. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-19.

Sponsored by University Hospital, Lille · Observational

How we know

From the registry’s dates

  • Started May 2024; still recruiting 2 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
165
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 38 studies in Osteoarthritis, Hip with a site in France — 10 open to participants now, 16 under way, none of them phase 3. Osteoarthritis, Hip · France.

Planned enrollment
13th of 17
165 · median 250
Started
2024
with 6 others
Observational
17 of 38
6 open now
Primary completion
2026-08
later than 7 of 15 live
Registered
34th of 38
by date
Lead sponsor
2 of 38
University Hospital, Lille

Among the 38 studies in Osteoarthritis, Hip with a site in France, this one is the 13th largest by planned enrollment of the 17 observational ones that give a count, is one of 7 that started in 2024, is one of 17 observational ones, reaches primary completion later than 7 of the 15 other live ones, and was the 34th registered.

Osteoarthritis, Hip

642 studies on the registry are indexed under Osteoarthritis, Hip; 120 are open to participants now.

Browse Osteoarthritis, Hip studies →

Open to participants now

10 of the 38 studies in Osteoarthritis, Hip with a site in France are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 86 Osteoarthritis, Hip studies recruiting now, 53 (62%) set no upper age limit and 7 (8%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 38 studies in Osteoarthritis, Hip with a site in France, or all of them as a file.
02

Study summary

The study will analyze hip biomechanical parameters using EOS radiographic measurements pre- and post-operatively (3 months) and post-operatively (3 months) CT scans after total hip replacement (THR), neck-preserving THR of the Minihip type or hip resurfacing (HR). Clinical results will be assessed at 3 months and 1 year after surgery.

To this end, two types of examination are carried out, both of which are used in current practice:

  • Pre-operatively: EOS radiography
  • Post-operatively: EOS radiograph and CT scan

Inclusion (m-3; m-1) :

  • Patient information at pre-operative visit
  • Non-opposition of patient, family member or legal guardian, if applicable
  • Questionnaires and clinical examination (standard management)
  • EOS during anesthetic consultation

Follow-up visit (m+3):

- Post-operative follow-up consultation EOS and CT scan (1 week prior to visit) + questionnaire and clinical examination

Follow-up visit (m+12):

- Post-operative check-up, questionnaire and clinical examination

03

Conditions studied

  • Coxarthrosis

Browse trials for

Keywords

  • Arthroplasty hip
  • femoral offset
  • resurfacing
  • EOS
  • 3D
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients, primary care clinic at Lille University Hospital, single-center study

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female
  • Age ≥ 18 years
  • Planned surgery: total hip arthroplasty, Minihip or RSA
  • Absence of osteoarthritis or osteoarthritis ≤ stage 1 (Tönnis classification) of contralateral hip (Radiographic analysis)
  • Patient having given his/her non-opposition to participate in the study
  • Patient with social insurance
  • Patient willing to comply with all study procedures and duration

Exclusion criteria

Exclusion Criteria:

  • Patient with comorbidity(ies) likely to affect biomechanical parameter measurements or surgical conditions:
  • Anomalies or anatomical changes of the hip, pelvis or lumbar spine (history of fracture, protrusion, scoliosis, history of orthopedic surgery, dysplasia, torsion disorder)
  • Established genetic disease affecting the musculoskeletal system
  • Severe or morbid obesity
  • Neuromuscular pathologies affecting the limb girdles
  • Severe osteoporosis
  • Bone location of primary or cancer (spine, pelvis or femur) - Inequality of lower limb length > 2 cm.
  • Minors
  • Protected adults
  • Pregnant or breast-feeding women
  • Administrative reasons: inability to receive informed information, inability to participate in the entire study, lack of social security coverage, refusal to participate.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
165 participants (estimated)
Patient registry
No

Groups and cohorts

  • total hip arthroplasty (THA)

    Standard THA, the head and neck of the femur are cut.

    Procedure: hip arthroplasty

  • Total hip prosthesis with femoral neck preservation

    A total hip replacement is performed, but the neck of the femur is preserved and the head of the femur is cut off.

    Procedure: hip arthroplasty

  • Hip resurfacing

    the head and neck of the femur are preserved.

    Procedure: hip arthroplasty

Interventions

  • Procedurehip arthroplasty

    resurfacing procedures (HRP), THA and Minihip-type neck-preserving total hip arthroplasty.

06

What researchers measure

Primary outcomes

  1. Comparing the restoration of femoral hip offset between hip resurfacing procedures (HRP), THA and Minihip-type neck-preserving total hip arthroplasty.

    The primary endpoint will be the difference between the native femoral offset, measured on the healthy contralateral hip, and the postoperative femoral offset of the operated hip. The offset is the distance in millimeters between the axis of the femoral shaft and the center of the femoral head.

    Time frame: It will be measured using CT scans at 3 months post-op for each hip.

Secondary outcomes

  1. Compare the anatomical restoration of frontal and axial parameters between the 3 types of intervention (PTH, Minihip and RSA).

    Difference between the contralateral healthy hip and the operated hip at 3 months post-op of the following parameters: * frontal parameters: CCD angle (in degrees), limb length, LLL discrepancy (vertical femoral offset in mm), femoral or prosthetic head diameter, acetabulum inclination on the healthy side and cup inclination on the operated side, head-neck ratio (ratio between the diameter of the neck and the head of the femur). * axial parameters: femoral or prosthetic neck version, acetabulum version on healthy side and cup version on operated side, total version (neck + acetabulum or cup).

    Time frame: 3 months post-op

  2. Compare clinical outcomes and patient satisfaction between the 3 procedures (PTH, Minihip and RSA).

    Variations between the pre-operative and post-operative 3-month and 1-year periods in the following clinical parameters: Oxford, Harris, PMA, Devane, UCLA, Forgotten Joint Score Hip (FJS hip), joint amplitudes, ILMI clinical estimate (in cm) \- Patient satisfaction: measured using a 4-item MCQ (dissatisfied, not very satisfied, satisfied, very satisfied) at 3 months (early recovery) and 1 year (definitive recovery).

    Time frame: 3 months then 1 year post-op

  3. Correlate restoration of hip femoral offset and patient functional outcome at 3 months.

    Offset restoration, defined as the difference between the native femoral offset, measured on the healthy contralateral hip, and the postoperative femoral offset of the operated hip. \- Patient functional outcome, defined by the Oxford score.

    Time frame: 3 months post-op

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Aug 2026, 27 months after the start.

Of 52 non-industry observational studies under Osteoarthritis, Hip, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 59. This study's planned 27 months is above that.

Counting every sponsor, half of 81 studies reached it within 53 months; a quarter within 13 and three quarters within 113.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 15, 2024
First posted
Feb 22, 2024
StartActual
May 27, 2024
Primary completionEst.
Aug 27, 2026
CompletionEst.
Aug 27, 2026
Last update
May 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06272422
Responsible party
Sponsor
First posted
Feb 22, 2024
Start date
May 27, 2024
Primary completion
Aug 27, 2026 (estimated)
Completion
Aug 27, 2026 (estimated)
Last update
May 19, 2026

Study contacts

Julien GIRARD, MD
Contact
julien.girard@chu-lille.fr
+33 (0)3.20.44.68.28

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion